Publications

5539 Results

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

Authors
G Arpino;SJ Green;DC Allred;D Lew;S Martino;CK Osborne;RM Elledge
Journal / Conference
Clinical Cancer Research 10:5670-5676
Year
2004
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited stage small cell lung cancer (S0004): a Southwest Oncology Group study

Authors
QT Le;J McCoy;S Williamson;J Ryu;LE Gaspar;M Edelman;S Dakhil;SD Sides;JJ Crowley;DR Gandara
Journal / Conference
Clinical Cancer Research 10:5418-5424
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0004

Tirapazamine plus cisplatin in advanced or recurrent squamous or adenosquamous carcinoma of the uterine cervix: a phase II study of the Southwest Oncology Group

Authors
HO Smith;C Jiang;GR Weiss;AV Hallum;PY Liu;AM Miller;DR Gandara;M Markman;DS Alberts
Journal / Conference
Gynecologic Oncology 92:416 (#49)
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
S9717

Prevalence of prostate cancer among men with a prostate-specific antigen level < 4.0 ng per milliliter

Authors
IM Thompson;DK Pauler;PJ Goodman;CM Tangen;MS Lucia;HL Parnes;LM Minasian;LG Ford;SM LIppman;ED Crawford;JJ Crowley;CA Coltman Jr
Journal / Conference
New England Journal of Medicine 350(22):2239-2246
Year
2004
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Surgical factors influence bladder cancer outcomes: a Cooperative Group report

Authors
HW Herr;JR Faulkner;HB Grossman;RB Natale;R de Vere White;MF Sarosdy;ED Crawford
Journal / Conference
Journal of Clinical Oncology 22(14):2781-2789
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Pathologic evaluation of radical cystectomy specimens: a Cooperative Group report

Authors
HW Herr;JR Faulkner;HB Grossman;ED Crawford
Journal / Conference
Cancer 100(11):2470-2475
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials

Authors
CM Tangen;PJ Goodman;JJ Crowley;IM Thompson
Journal / Conference
Journal of Urology 171:S64-S67
Year
2004
Research Committee(s)
Cancer Control and Prevention and Epidemiology
Study Number(s)
S0000, SWOG-9217

A phase II study of cisplatin preceded by a 12-hour continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas

Authors
H Carraway;LJ Swinnen;C Rankin;KS Albain;JJ Townsend;D Blumenthal
Journal / Conference
Neuro-Oncology 6(4):372 (TA-10)
Year
2004
Research Committee(s)
Brain
Study Number(s)
SWOG-9149

Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition

Authors
DR Gandara;H West;K Chansky;AM Davies;DHM Lau;J Crowley;PH Gumerlock;FR Hirsh;WA Franklin
Journal / Conference
Clinical Cancer Research 10 (Suppl):4205s-4209s
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0126, S9714

Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells

Authors
DE Banker;SJ Mayer;HY Li;CL Willman;FR Appelbaum;RA Zager
Journal / Conference
Blood 104(6):1816-1824
Year
2004
Research Committee(s)
Leukemia